
- Telehealth Visits
- Insurance plan information
- Provider Type: Physician

Neil P. Shah, MD, PhD
Hematology and Medical Oncology- Telehealth Visits
- Insurance plan information
- Provider Type: Physician



Neil P. Shah, MD, PhD
Hematology and Medical OncologyOn this page
Education & training
Board certification
- Hematology, American Board of Internal Medicine/Hematology
Fellowship
- Hematology - Oncology, University of California Los Angeles
Residency
- Internal Medicine, University of California Los Angeles
Degree
- MD, University of California Los Angeles
Academic title
- Professor-in-Residence
My expertise
Locations
My research
Publications
Showing 1-6 of 62 reviews
- September 5, 20265 out of 5 Stars
The best doctor ever. He really cares and he is really really good at he does.
- September 5, 20265 out of 5 Stars
Discussed a possible new treatment plan. My questions were answered fully and the final decision will be made by me. I am entirely satisfied with the discussion.
- August 20, 20265 out of 5 Stars
Good
- August 14, 20265 out of 5 Stars
Wonderful care provider, informed and effective.
- July 30, 20265 out of 5 Stars
Dr. Neil Shah is an outstanding doctor and a wonderful person. He goes above and beyond to inform me and make me feel safe. I feel very fortunate to have him as my Oncologist.
- July 14, 20265 out of 5 Stars
Dr. Shah is the best. He is always looking out for Me and my other issues. He recommended I enroll in the UCSF headache clinic. Always compassionate. Always kind. I'm always grateful for his care.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.